Product Information
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $6.3566 per EA under NDC 33342028607. Its NADAC has been published 69 times since Mar 5, 2025.
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB
amlodipine,valsartan and hydrochlorothiazideStrength
10; 25; 160 mg/1; mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342028607
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA207299On Market Since
1/6/2025
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has been published 69 times since Mar 5, 2025, and over the history we have for it it has declined 14.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3566 per EA |
|---|---|
| All-time high | $8.3788 (Oct 15, 2025) |
| All-time low | $6.3566 (Jun 17, 2026) |
| 52-week high | $8.3788 |
| 52-week low | $6.3566 |
| Median price | $7.7106 |
| Average price | $7.6998 |
| Largest weekly change | -6.8% (May 20, 2026) |
| Weeks tracked | 69 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the amlodipine,valsartan and hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $6.3566 per EA (NDC 33342028607), effective Jun 24, 2026.
How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has declined 14.5%. It has been tracked across 69 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
Since Mar 5, 2025, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has ranged from a low of $6.3566 (Jun 17, 2026) to a high of $8.3788 (Oct 15, 2025), with a median of $7.7106 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB (NDC 33342028607) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification